BYOT Byotrol Plc

TIDMBYOT

RNS Number : 0342L

Byotrol PLC

03 September 2019

Byotrol plc

Notice of Results

Byotrol plc, the specialist anti-microbial technology company, announces that it will be releasing its audited results for the year ended 31 March 2019, no later than 27 September, 2019.

Enquiries:

David Traynor - Chief Executive, Byotrol plc 01925 742 000

Nic Hellyer - Chief Financial Officer, Byotrol plc

01925 742 000

finnCap Ltd 020 7220 0500 (Nominated Adviser & Broker)

Geoff Nash/Kate Bannatyne- Corporate Finance

Richard Chambers - Corporate Broking

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies. Our patented suite of technologies deliver powerful broad-spectrum efficacy with long-lasting performance, optimised against commonly occurring and industry-specific pathogens.

Founded in 2005, the Company has developed advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.

For more information, please go to www.byotrol.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NORUGUQUBUPBURW

(END) Dow Jones Newswires

September 03, 2019 04:08 ET (08:08 GMT)

Byotrol (LSE:BYOT)
Historical Stock Chart
From Apr 2024 to May 2024

Byotrol (LSE:BYOT)
Historical Stock Chart
From May 2023 to May 2024